ArticleHemaSphere2021

Detailed Long-Term Follow-Up of Patients Who Relapsed After the Nordic Mantle Cell Lymphoma Trials: MCL2 and MCL3.

Christian Winther Eskelund et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.